http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-172045-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80f9f6e939f5a2e10c0e9478c70b4b0e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-44
filingDate 1993-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a2613cb9b85d3e65eb2663e22fd2258
publicationDate 1997-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-172045-B1
titleOfInvention 4- (2-aryl / alkyl / amino-1-oxoethyl) -1,2,3,4-tetrahydro-2-quinoxalinones and 4- (2-aryl / alkyl) amino-1-oxoethyl) -1 , 2,3,4-tetrahydro-2-quinoxalinones PL
abstract 1. 4- (2-aryl (alkyl) amino-1-oxoethyl) - 1,2,3,4-tetrahydro-2-quinoxalinones of the formula 1, where R 1 = R 2 and is hydrogen or a methyl residue, and R 3 is a benzyl residue or an ethoxyphenyl residue. 2. Method for the preparation of 4- (2-aryl (alkyl) amino-1-oxoethyl) - 1,2,3,4-tetrahydro-2-quinoxalinones by the reaction of N, N '- bis (chloroacetyl) -o-phenylenediamine with aliphatic or aromatic amines, characterized in that the substrates are used in a 1: 1 ratio, where the reactions are carried out in an organic solvent environment in the presence of a hydrogen chloride acceptor at a temperature of 20 ° -145 °, and the obtained product is then isolated and cleanses. PL
priorityDate 1993-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465046548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415868721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420312335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4555956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID374863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID185949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426038319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53901957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2436038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465269828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448098817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457270017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465259084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449831254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228

Total number of triples: 49.